Newomics Founder and CEO Dr. Daojing Wang will present our MEA chip technologies for “Quantitation of Intact Proteins in Human Plasma Using Top-Down Parallel Reaction Monitoring-MS”, at 11:20 am, April 3, at 2019 MSACL (Mass Spectrometry: Applications to the Clinical Lab).
